Navigation Links
Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
Date:9/26/2007

RX-101, a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life-threatening kidney disease caused by diabetes. Sulonex is in a pivotal Phase 3 and Phase 4 clinical program under a Special Protocol Assessment with the Food & Drug Administration. Additionally, Keryx is developing Zerenex(TM), an oral, iron- based compound that has the capacity to bind phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated serum phosphorous levels) in patients with end- stage renal disease. Keryx is also developing clinical-stage oncology compounds, including KRX-0401 (perifosine), a novel, first-in-class, oral modulator of Akt, a pathway associated with tumor survival and growth, and other important signal transduction pathways. KRX- 0401 is currently in Phase 2 clinical development for multiple tumor types. Keryx also has an active in-licensing and acquisition program designed to identify and acquire additional drug candidates. Keryx is headquartered in New York City.

About Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd.

Japan Tobacco Inc. is the world's third largest international manufacturer of tobacco products. Since its privatization in 1985, JT has actively diversified its operations into pharmaceuticals and foods. JT entered into the pharmaceutical business in 1987 and established the Central Pharmaceutical Research Institute in 1993. JT is currently engaged in the research and development of new drugs in various areas such as glucose and lipid metabolism, anti-virus, immune disorders and inflammation, and bone metabolism. The company's net sales were 4.769 trillion yen in the fiscal year that ended March 31, 2007.

Torii Pharmaceutical Co., Ltd., established in 1921, has manufactured and distributed ethical pharmaceutical products. In 1998, Torii became a member of the JT Group. To maximally leverage the synergy of the Group,
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. WARF enters licensing agreements for stem cell products
2. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
3. Software company enters health space with RFID solutions on hold
4. Lucigen Corp. enters global licensing agreement
5. Call centers and customer service: The good, the bad, and the clueless
6. GE Healthcare enters agreement with Canadian health authority
7. Data centers: Buyers beware of over-hyped facilities
8. Data centers: Blowing smoke and raising red flags
9. Prodesse enters patent agreement with Roche
10. UW-Madison enters Kauffman grant competition
11. Applied Technology Centers to aid printing and manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... DUBLIN , Sept. 29, 2014 ... "Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph ... Application, & Region - Global Trends & Forecast to ... A process analyzer is a process analytical ... in real-time. It has redefined the way by which ...
(Date:9/29/2014)... (PRWEB) September 29, 2014 Transparency Market ... Synthesis - SPPS, LPPS, HPPS, by Application - Cancer, ... & Generic and by Delivery) - Global Industry Analysis, ... states that the global peptide therapeutics market was worth ... US$25.4 billion by 2018 at an 8.7% CAGR. , ...
(Date:9/29/2014)... CAMBRIDGE, Mass. , Sept. 29, 2014  Atlas ... promising life sciences and technology innovation, today announced that ... of Epizyme (NASDAQ: EPZM ), is joining ... effective October 1, 2014. At Atlas, Rhodes ... build groundbreaking companies. He brings an accomplished record in ...
(Date:9/29/2014)... /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), ... technologies and products for advanced microarray diagnostics, is pleased ... to Chairman of the Board of Directors of SQI, ... to serve as a Director on the Board and ... "We are very pleased to have Mr. ...
Breaking Biology Technology:Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 2Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 3Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 4Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 2Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 3Atlas Venture Names Jason Rhodes, Veteran Investor and President and CFO of Epizyme, As Partner on Life Sciences Investing Team 2SQI Diagnostics Announces New Chairman of Board of Directors 2
... ... Improves Bowel Function, CAMBRIDGE, England, September 26 The ... patients with chronic severe pain,compared to treatment with oxycodone alone, according ... Congress, Budapest(1). A Phase III trial of 463 patients was ...
... Next Generation Sequence Analysis Problem -, - Exhibit ... Tool -, MISSION VIEJO, Calif., Sept. 26 ... its innovative genomic search,technology, SLIM Search, Inc. announces ... Second International Next Generation,Sequencing Conference. The conference will ...
... as President and CSO, MONTREAL and SAN ... held biotechnology company developing,first-in-class Leukocyte Population Modulators (LPMs) ... Jack M. Anthony to Chief,Executive Officer. Dr. Philip ... continue as President and assume the new role ...
Cached Biology Technology:New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain 2New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain 3SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market 2SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market 3SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market 4Osprey Pharmaceuticals Names Jack M. Anthony as CEO 2Osprey Pharmaceuticals Names Jack M. Anthony as CEO 3
(Date:9/29/2014)... in Behavioral Brain Research provides novel insight ... result of chronic alcohol exposure that can lead to ... and research indicate that individuals with alcohol use disorders ... when people are actively drinking, when they are going ... "Sleep-wake disturbances can last for months, or even years, ...
(Date:9/29/2014)... deemed inaccessible or esoteric. Yet in the modern world, ... daily lives and a decisive role in the discovery ... scenes. , UC Santa Barbara,s Paul Atzberger, a professor ... of mechanical engineering, often works in areas where science ... in the Proceedings of the National Academy of ...
(Date:9/29/2014)... the supercontinent of Pangea was starting to break up and ... of reptiles called phytosaurs and rauisuchids were at the top ... two top predators didn,t interact much as the former was ... But those ideas are changing, thanks largely to the contents ... in September in the German journal Naturwissenschaften ...
Breaking Biology News(10 mins):At the interface of math and science 2At the interface of math and science 3At the interface of math and science 4Tooth buried in bone shows prehistoric predators tangled across land, sea 2
... physical world. That,s a fact cancer researchers are beginning to ... mathematics in their efforts to understand how cancer develops -- ... researchers at the University of Michigan Comprehensive Cancer Center, has ... of the top cancer research journals and a new grant ...
... once discussed only in scientific or eco-centric circles, has ... sustainability remains elusive. On Friday, scholars and legal ... address how to meet mankind,s present needs without compromising ... The Environmental & Energy Law & Policy Journal,s fifth ...
... chemicals from plant material could produce liquid fuel for just ... the infrastructure is set up in the right way, states ... Bioproducts & Biorefining . Developed by scientists at the ... as bioliq, and is able to produce a range of ...
Cached Biology News:Physics, math provide clues to unraveling cancer 2Symposium at UH will address how to put 'sustainability' into practice 2Novel technology could produce biofuel for around 0.50 a liter ($2.49 a gallon) 2
... Electrophoresis Running Buffer was designed to meet ... of todays sequencing labs. As a primary ... the gel-based sequencing community Sigma has the ... meet your buffer needs. Scientists at Sigma ...
... Excalibur™ mid-, near- and far-infrared range FT-IR ... performance in their class. Yet all this ... Features: Highest-energy throughput: Having a larger ... compared to other conventional FT-IRs provides 300%,larger ...
... 8800 Genetic Analysis System, which processes two 96-well ... system adds a higher level of throughput to ... part of Beckman Coulters new GenomeLab family of ... the Biomek series liquid handers, for increased automation. ...
... cDNA Library Panels were designed for full-length ... of PCRs to identify the desired cDNA ... in a 96-well "Master Plate," where each ... Having identified the positive well(s) by gel ...
Biology Products: